Sivik Global Healthcare
Latest statistics and disclosures from Sivik Global Healthcare's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Put - Spy 100 @ 505 Exp 04/19/2024, XBI, LLY, NVO, BSX, and represent 50.06% of Sivik Global Healthcare's stock portfolio.
- Added to shares of these 10 stocks: Put - Spy 100 @ 505 Exp 04/19/2024 (+$152M), XBI (+$16M), CRL (+$6.8M), EW (+$6.7M), BAX (+$5.6M), AVTR (+$5.5M), WST, BDX, OPCH, GEHC.
- Started 16 new stock positions in CRL, WST, GEHC, RVTY, AVTR, BNTX, BDX, GPCR, Put - Spy 100 @ 505 Exp 04/19/2024, BAX. CTLT, NTRA, TEVA, OPCH, EW, MEDP.
- Reduced shares in these 10 stocks: HCA (-$7.5M), THC (-$7.4M), MDT (-$6.6M), ZBH (-$6.1M), UHS (-$5.0M), , , , , BIIB.
- Sold out of its positions in COR, DVA, LH, DGX, WBA, ZBH, MDT, Qiagen Nv.
- Sivik Global Healthcare was a net buyer of stock by $164M.
- Sivik Global Healthcare has $427M in assets under management (AUM), dropping by 78.22%.
- Central Index Key (CIK): 0001596452
Tip: Access up to 7 years of quarterly data
Positions held by Sivik Global Healthcare consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Sivik Global Healthcare
Sivik Global Healthcare holds 47 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Put - Spy 100 @ 505 Exp 04/19/2024 Put Put Option | 35.5 | $152M | NEW | 3.0k | 50500.00 |
|
| Spdr S&p Biotech Etf S&p Biotech (XBI) | 6.7 | $29M | +121% | 300k | 94.89 |
|
| Eli Lilly & Co. (LLY) | 2.9 | $12M | +6% | 16k | 777.94 |
|
| Novo-nordisk A/s Adr (NVO) | 2.8 | $12M | +2% | 93k | 128.40 |
|
| Boston Scientific Corporation (BSX) | 2.2 | $9.2M | -15% | 135k | 68.49 |
|
| Thermo Fisher Scientific (TMO) | 2.1 | $9.0M | +29% | 16k | 581.23 |
|
| Stryker Corporation (SYK) | 2.1 | $8.9M | -10% | 25k | 357.88 |
|
| Intuitive Surg Com New (ISRG) | 1.9 | $8.0M | -11% | 20k | 399.10 |
|
| Tenet Healthcare Com New (THC) | 1.8 | $7.9M | -48% | 75k | 105.11 |
|
| McKesson Corporation (MCK) | 1.8 | $7.8M | -3% | 15k | 536.83 |
|
| Danaher Corporation (DHR) | 1.8 | $7.5M | +20% | 30k | 249.73 |
|
| Univ Health Svc Class B (UHS) | 1.7 | $7.3M | -40% | 40k | 182.45 |
|
| ResMed (RMD) | 1.6 | $7.0M | +76% | 35k | 198.04 |
|
| Humana (HUM) | 1.6 | $6.9M | +33% | 20k | 346.70 |
|
| Charles River Laboratories (CRL) | 1.6 | $6.8M | NEW | 25k | 270.96 |
|
| Edwards Lifesciences (EW) | 1.6 | $6.7M | NEW | 70k | 95.56 |
|
| Select Medical Holdings Corporation (SEM) | 1.4 | $6.0M | -20% | 200k | 30.15 |
|
| Inspire Med Sys (INSP) | 1.4 | $5.9M | 28k | 214.80 |
|
|
| Hca Holdings (HCA) | 1.4 | $5.8M | -56% | 18k | 333.54 |
|
| Abbott Laboratories (ABT) | 1.3 | $5.7M | -4% | 50k | 113.66 |
|
| Surgery Partners (SGRY) | 1.3 | $5.7M | -5% | 190k | 29.83 |
|
| Baxter International (BAX) | 1.3 | $5.6M | NEW | 130k | 42.74 |
|
| Acadia Healthcare (ACHC) | 1.3 | $5.5M | -22% | 70k | 79.21 |
|
| Avantor (AVTR) | 1.3 | $5.5M | NEW | 214k | 25.57 |
|
| Smith & Nephew Spdn Adr New (SNN) | 1.2 | $5.2M | +7% | 205k | 25.36 |
|
| Insulet Corporation (PODD) | 1.2 | $5.1M | +13% | 30k | 171.40 |
|
| Cardinal Health (CAH) | 1.2 | $5.0M | +12% | 45k | 111.91 |
|
| BioMarin Pharmaceutical (BMRN) | 1.2 | $5.0M | +4% | 58k | 87.34 |
|
| Encompass Health Corp (EHC) | 1.2 | $5.0M | -33% | 60k | 82.58 |
|
| UnitedHealth (UNH) | 1.2 | $4.9M | 10k | 494.70 |
|
|
| Dex (DXCM) | 1.1 | $4.9M | -30% | 35k | 138.71 |
|
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.1 | $4.6M | -12% | 11k | 418.00 |
|
| West Pharmaceutical Services (WST) | 0.9 | $4.0M | NEW | 10k | 395.70 |
|
| Becton, Dickinson and (BDX) | 0.9 | $3.7M | NEW | 15k | 247.47 |
|
| Option Care Health Com New (OPCH) | 0.9 | $3.7M | NEW | 110k | 33.54 |
|
| Ge Healthcare Technology Common Stock (GEHC) | 0.9 | $3.6M | NEW | 40k | 90.90 |
|
| Cigna Corp (CI) | 0.9 | $3.6M | -42% | 10k | 363.20 |
|
| Natera (NTRA) | 0.8 | $3.2M | NEW | 35k | 91.46 |
|
| Maravai Lifesciences Hldgs-a Com Cl A (MRVI) | 0.7 | $3.2M | +77% | 365k | 8.67 |
|
| PerkinElmer (RVTY) | 0.7 | $3.2M | NEW | 30k | 105.00 |
|
| Medpace Hldgs (MEDP) | 0.7 | $3.0M | NEW | 7.5k | 404.13 |
|
| Catalent (CTLT) | 0.7 | $2.8M | NEW | 50k | 56.46 |
|
| Stevanato Group S P A (STVN) | 0.6 | $2.7M | +3% | 83k | 32.11 |
|
| Teva Pharm Sponsored Ads (TEVA) | 0.6 | $2.5M | NEW | 175k | 14.11 |
|
| Biontech Se Sponsored Ads (BNTX) | 0.5 | $2.3M | NEW | 25k | 92.24 |
|
| Biogen Idec (BIIB) | 0.5 | $2.2M | -59% | 10k | 215.67 |
|
| Structure Therapeutics Sponsored Ads (GPCR) | 0.0 | $191k | NEW | 4.5k | 42.79 |
|
Past Filings by Sivik Global Healthcare
SEC 13F filings are viewable for Sivik Global Healthcare going back to 2013
- Sivik Global Healthcare 2024 Q1 filed May 1, 2024
- Sivik Global Healthcare 2023 Q4 filed Feb. 5, 2024
- Sivik Global Healthcare 2023 Q3 filed Nov. 7, 2023
- Sivik Global Healthcare 2023 Q2 filed Aug. 9, 2023
- Sivik Global Healthcare 2023 Q1 filed May 8, 2023
- Sivik Global Healthcare 2022 Q4 filed Feb. 8, 2023
- Sivik Global Healthcare 2022 Q3 filed Nov. 4, 2022
- Sivik Global Healthcare 2022 Q2 filed Aug. 10, 2022
- Sivik Global Healthcare 2022 Q1 filed May 9, 2022
- Sivik Global Healthcare 2021 Q4 filed Feb. 8, 2022
- Sivik Global Healthcare 2021 Q3 filed Nov. 12, 2021
- Sivik Global Healthcare 2021 Q2 filed Aug. 10, 2021
- Sivik Global Healthcare 2021 Q1 filed May 12, 2021
- Sivik Global Healthcare 2020 Q4 filed Feb. 16, 2021
- Sivik Global Healthcare 2020 Q3 filed Nov. 13, 2020
- Sivik Global Healthcare 2020 Q2 filed Aug. 14, 2020